EDTUTC-4 New YorkLog in Sign up

ALNY
Alnylam Pharmaceuticals, Inc.
stockNASDAQ

At CloseOct 2, 2026 3:59:53 PM EDT

219.90USD-4.879%(-11.28)1,661,854

Pre-marketOct 2, 2026 9:19:30 AM EDT

231.93USD+0.324%(+0.75)

After-hoursOct 2, 2026 4:39:30 PM EDT

219.72USD-0.082%(-0.18)

ALNY News

Day breaks

11:30 AM EDTNotable ETF Inflow Detected - TCAF, CNP, ALNY, KDP ·

BNK Invest

05:43 AM EDT18 of 21 Analysts Still Think Alnylam Stock Is a Buy. Here's Why They're Right. ·

The Motley Fool

05:23 AM EDT18 of 21 Analysts Still Think Alnylam Stock Is a Buy. Here's Why They're Right. ·

The Motley Fool

02:57 PM EDTFDA, Duke-Margolis workshop to examine evidence standards for rare diseases ·

Seeking Alpha

10:00 AM EDT10 large and mega-cap U.S. healthcare stocks with the weakest momentum grades ·

Seeking Alpha

04:08 PM EDTAlnylam Pharmaceuticals, Inc. (ALNY) Discusses Zilebesiran and the Potential of RNAi Therapeutics for Continuous Blood Pressure Control Transcript ·

Seeking Alpha

05:58 AM EDTOligonucleotide Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Ionis Pharmaceuticals, and Sarepta Therapeutics ·

GlobeNewswire Inc.

04:44 AM EDTAlnylam's Sell-Off Looks Ugly -- but Wall Street Still Sees a Much Brighter Picture ·

The Motley Fool

11:30 AM EDTTG Therapeutics (TGTX) Up 15.1% Since Last Earnings Report: Can It Continue? ·

Zacks Investment Research